Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Swallowing Air-Pulse Therapy System

The University of Western Ontario - Industry Liaison
Western researchers have developed a novel technique, Swallowing Air-Pulse Therapy (SWAPT) and an associated device Swallowing Air-Pulse Therapy System (SWAPTS).

Full description

Key Words: Swallowing disorders, dysphagia, stroke rehabilitation, head & neck cancer 

DESCRIPTION OF INVENTION: Western researchers have developed a novel technique, Swallowing Air-Pulse Therapy (SWAPT) and an associated device Swallowing Air-Pulse Therapy System (SWAPTS). The technique involves directing computer-controlled trains of discrete air pulses to the posterior part of the mouth, near the tonsil. This “peritonsillar” region is known to be an important anatomic site for evoking swallowing based on evidence from animal and human studies.

BACKGROUND: Swallowing impairment, or dysphagia, is a devastating condition that occurs due to disease or damage to the neural or structural systems that give rise to swallowing. Dysphagia compounds major health problems by substantially increasing a patient’s risk of pneumonia, malnutrition, prolonged hospitalization, and death, resulting in tremendous personal suffering and health care costs. Dysphagia affects 17 million North Americans of all ages and most common among the elderly. Its prevalence is expected to increase dramatically as the population ages over the next three decades.

In spite of the significant burden of dysphagia, and although sophisticated diagnostic methods have been developed, effective swallowing therapies are lacking. Indeed, swallowing management in most hospitals is limited to diet modification and exercises.

POTENTIAL ADVANTAGES/USES:
SWAPT could be used for both therapeutic and diagnostic purposes and presents a number of advantages over the existing treatments:

  • Can evoke an irrepressible urge to swallow followed by an overt swallow.
  • Does not require the patient to follow instructions or produce any movements of the mouth.
  • A portable SWAPT device will provide easy use by patients, and elderly adults at home
  • The SWAPT system will include a visual feedback display allowing the patient to “see” the movement of
  • his/her larynx during swallowing. This will allow patients to monitor their progress.
  • Greater patient safety and comfort, use in patients for whom electrical stimulation is contraindicated (e.g. pacemaker, heart conditions).
  • Relatively un-invasive compared to existing procedures


DEVELOPMENTAL STAGE: Proof-of-Principle, clinical trial

Ref. #s: UWO-AF-027; UWO-AH-001

* This technology has been developed with support from Canadian Institute of Health Research (CIHR)

Development status

Preclinical

Patent information

US full patent and PCT applications filed

Type of business relationship sought

This technology is available for outlicensing - a collaborative research approach is welcome

Partnering consultation free of charge
Need competitive intelligence information
Clinical Outsourcing World
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us